The group’s principle activities include discovering, developing and commercializing of proprietary drugs. The group also provides protective countermeasues against bioterrorism and on the prevention and mitigation of Alzheimer's disease. The group’s products include BIO 300 and NIC5-15,and BIO 400. The group operates from United States.
